Solventum Corp | SOLV - Selling And Administration Expenses


Solventum Corp reported $744M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Align Technology USD 417.8M 30.89M Sep/2025
Baxter International USD 708M 10M Sep/2025
Becton, Dickinson and Co. USD 1.37B 46M Sep/2025
Cencora USD 1.75B 75.99M Sep/2025
Dexcom USD 331.4M 3.4M Sep/2025
Insulet USD 315.2M 61.9M Sep/2025
Solventum Corp USD 744M 28M Sep/2025
West Pharmaceutical Services USD 102.7M 6.8M Sep/2025
Zimmer Biomet Holdings USD 811.4M 3.4M Sep/2025